HLA typing in idiopathic hemochromatosis: Distinction between homozygotes and heterozygotes with biochemical expression

Mark L. Bassett, June W. Halliday, Lawrie W. Powell – 1 March 1981 – In a study of 20 families with idiopathic hemochromatosis, relatives of probands were classified as either homozygous, heterozygous, or normal according to their HLA phenotype. An abnormality in the serum iron concentration, total iron‐binding capacity, or serum ferritin concentration was present in all homozygotes and in 25% of heterozygotes. In heterozygotes, the mean total iron‐binding capacity was significantly decreased, and the mean hepatic iron concentration was significantly increased compared to normals.

Prognostic indicators of hepatic injury following jejunoileal bypass performed for refractory obesity: A prospective study

Norman W. Haines, Alfred L. Baker, James L. Boyer, Seymour Glagov, Harvey Schneir, Jonathan Jaspan, Donald J. Ferguson – 1 March 1981 – To evaluate factors predisposing to liver injury following jejunoileal bypass, 27 patients underwent clinical evaluation and liver biopsy prior to bypass and at 3, 6, 12, 18, and 24 months and yearly thereafter.

Distal splenorenal shunt vs. portal‐systemic shunt: Current status of a controlled trial

H. O. Conn, R. H. Resnick, N. D. Grace, C. E. Atterbury, D. Horst, R. J. Groszmann, P. Gazmuri, R. J. Gusberg, B. Thayer, D. Berk, S. C. Wright, R. Vollman, D. M. Tilson, W. V. McDermott, J. A. Cohen, M. Kerstein, A. L. Toole, J. P. Maselli, S. Razvi, A. Ishihara, H. Stern, C. Trey, E. T. O'hara, W. Widrich, H. Aisenberg, H. C. Stansel, M.

Bile acid metabolism in cirrhosiso. VII. Evidence for defective feedback control of bile acid synthesis

Z. Reno Vlahcevic, Marc Goldman, Charles C. Schwartz, Jan Gustafsson, Leon Swell – 1 March 1981 – The present report has been directed toward providing additional information on the major defects in the bile acid pathways present in patients with cirrhosis and its relevance to the problem of how bile acid synthesis is regulated in man. An unusual patient with severe liver disease and a completely broken enterohepatic circuit was studied. The synthesis of cholic and chenodeoxycholic acids was examined over a 5‐d period.

The δ agent: HBsAg particles with δ antigen and RNA in the serum of an HBV carrier

Ferruccio Bonino, Bill Hoyer, Eugenie Ford, J. Wai‐Kuo Shih, Robert H. Purcell, John L. Gerin – 1 March 1981 – The hepatitis B virus‐associated delta antigen was detected in the serum of a young female drug addict with acute hepatitis and a previous history of hepatitis B surface antigen carrier. Delta antigen was associated with a 35‐ to 37‐nm subpopulation of hepatitis B surface antigen particles which banded at a density of 1.25 gm per cm3 of CsCl and contained a small RNA of approximately 5.5 × 105 molecular weight.

Woodchuck hepatitis and hepatocellular carcinoma: Correlation of histologic with virologic observations

Hans Popper, James W.‐K. Shih, John L. Gerin, Doris C. Wong, Bill H. Hoyer, William T. London, David L. Sly, Robert H. Purcell – 1 March 1981 – The livers of 33 captive woodchucks were examined histologically in 30 biopsy and 10 autopsy specimens and the findings were correlated with serum determinations for woodchuck hepatitis virus (WHV), surface antigen (WHsAg) and antibody (anti‐WHs), and WHV DNA and DNA polymerase.

Effect of short‐term ethanol administration on lorazepam clearance

Anasticio M. Hoyumpa, Rashmi Patwardhan, Michael Maples, Paul V. Desmond, Raymond F. Johnson, Alicia P. Sinclair, Steven Schenker – 1 January 1981 – The disposition of chlordiazepoxide (Librium®) and diazepam (Valium®), compounds which are initially degraded by oxidative processes, differs from that of oxazepam (Serax®) and lorazepam (Ativan®), drugs which are inactivated by conjugation with glucuronic acid. Liver disease and cimetidine impair the elimination of the former agents, but not the latter two benzodiazepines.

Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas

David A. Shafritz, Michael C. Kew – 1 January 1981 – DNA extracts from hepatocellular carcinomas of 13 patients from South Africa were examined for hepatitis B virus (HBV) DNA sequences by molecular hybridization using [32P]‐labeled recombinant, cloned, and purified HBV‐DNA. Eight patients were HBV carriers as demonstrated by the presence of hepatitis B surface antigen (HBsAg) in their serum, and each of these patients had HBV‐DNA sequences in hepatocellular carcinoma tissue. Five patients who were not HBsAg carriers, did not have HBV‐DNA in their tumors.

Subscribe to